Dyzantil 200 mg prolonged-release tablets

Manufacturer/MA Holder: Aspire Pharma Ltd
MA Number: PL 35533/0152

Important information

Please refer to the MHRA PREVENT Programme.

Drug Safety Category

2

Active Ingredient

Valproate (Sodium Valporate, Valproic Acid, Valproate Semisodium)

Formulation

Prolonged Release Tablet

Strength

200mg

Licensed for use with feeding tube

No

Confirmed as carbohydrate free

No

Length/Diameter

Unknown

SPC URL

Open SPC

Excipients of concern

Sodium Content18.43mg